Pathophysiology and Treatment of Hypertension in Dialysis Patients

作者: August Heidland , Roland M. Schaefer

DOI: 10.1007/978-1-4684-5718-6_9

关键词:

摘要: Before the start of regular dialysis treatment (RDT) prevalence hypertension averages between 75 and 90%l,2. During long-term RDT its declines markedly. The resulting inverse relationship duration elevated blood pressure (BP) is not only caused by early death hypertensive patients, but mainly due to antihypertensive effect itself. This BP-lowering relates normotensive patients. In a 10-year follow-up study percentage patients declined from 73 16%3. Hypertension disappeared in younger individuals, while it persisted or developed de-novo older showing characteristics systolic hypertension. observation underlines role age-related factors pathogenesis this type Interestingly, after 10 years was lower than an age- sex-matched population 4. these besides fluid salt removal dialysis, decrease dry weight, observed many 5 treatment, may contribute effect. It appears that prolonged sessions up 24 30 hours per week lead more effective control pressure. on 52 performed Charra5 normotension achieved strict maintenance weight alone (low diet, no drugs).

参考文章(74)
K Schafferhans, A Heidland, E Heidbreder, Disturbances of peripheral and autonomic nervous system in chronic renal failure: effects of hemodialysis and transplantation. Clinical Nephrology. ,vol. 23, pp. 222- 228 ,(1985)
U. Frei, B. Nonnast-Daniel, K. M. Koch, Erythropoietin und Hypertonie Journal of Molecular Medicine. ,vol. 66, pp. 914- 919 ,(1988) , 10.1007/BF01728954
Gavras H, Wauters Jp, Waeber B, Guignard Jp, Brunner Hr, Turini Ga, Uncontrollable hypertension in patients on hemodialysis: long-term treatment with captopril and salt subtraction. Clinical Nephrology. ,vol. 16, pp. 86- 92 ,(1981)
M.A. Schalekamp, D.G. Beevers, J.D. Briggs, J.J. Brown, D.L. Davies, R. Fraser, M. Lebel, A.F. Lever, A. Medina, J.J. Morton, J.I.S. Robertson, M. Tree, Hypertension in chronic renal failure The American Journal of Medicine. ,vol. 55, pp. 379- 390 ,(1973) , 10.1016/0002-9343(73)90137-X
G D Fink, L G Paulo, J W Fisher, Effects of beta adrenergic blocking agents on erythropoietin production in rabbits exposed to hypoxia. Journal of Pharmacology and Experimental Therapeutics. ,vol. 193, pp. 176- 181 ,(1975)
Andrew P. Goldberg, Edward M. Geltman, James R. Gavin, III, Robert M. Carney, James M. Hagberg, James A. Delmez, Anna Naumovich, Mary H. Oldfield, Herschel R. Harter, Exercise Training Reduces Coronary Risk and Effectively Rehabilitates Hemodialysis Patients Nephron. ,vol. 42, pp. 311- 316 ,(1986) , 10.1159/000183694
L Poston, R B Sewell, S P Wilkinson, P J Richardson, R Williams, E M Clarkson, G A MacGregor, H E de Wardener, Evidence for a circulating sodium transport inhibitor in essential hypertension. BMJ. ,vol. 282, pp. 847- 849 ,(1981) , 10.1136/BMJ.282.6267.847
Dominique Schohn, Peter Weidmann, Henri Jahn, Carlo Beretta-Piccoli, Norepinephrine-related mechanism in hypertension accompanying renal failure Kidney International. ,vol. 28, pp. 814- 822 ,(1985) , 10.1038/KI.1985.203
Pieter Klooker, Jürgen Bommer, Eberhard Ritz, Treatment of hypertension in dialysis patients. Blood Purification. ,vol. 3, pp. 15- 26 ,(1985) , 10.1159/000169395